Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: looks like PTSC bought back almost 1/2 million shares last quarter
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On April 28, 2006, our Board of Directors authorized a stock repurchase program. We commenced the program in July 2006 and plan to repurchase outstanding shares of our common stock on the open market from time to time. As part of the program, we purchased 448,300 shares of our common stock at an aggregate cost of $53,531 during the three months ended August 31, 2010.


Share
New Message
Please login to post a reply